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53% of the variance in gene expression among the top vari-
able genes and 19% of 28,351 genes were differentially 
expressed (false discovery rate <0.05) between the expo-
sure groups. Key genes regulating the immune system, 
such as tumor necrosis factor alpha and interferon gamma, 
as well as genes related to the NF-kappa-beta complex, 
were significantly downregulated in the high-arsenic group. 
Arsenic exposure was associated with genome-wide DNA 
methylation; the high-arsenic group had 3% points higher 
genome-wide full methylation (>80% methylation) than the 
lower-arsenic group. Differentially methylated regions that 
were hyper-methylated in the high-arsenic group showed 
enrichment for immune-related gene ontologies that con-
stitute the basic functions of CD4-positive T cells, such 
as isotype switching and lymphocyte activation and dif-
ferentiation. In conclusion, chronic arsenic exposure from 
drinking water was related to changes in the transcriptome 
and methylome of CD4-positive T cells, both genome wide 
and in specific genes, supporting the hypothesis that arsenic 
causes immunotoxicity by interfering with gene expression 
and regulation.
Abstract Arsenic, a carcinogen with immunotoxic effects, 
is a common contaminant of drinking water and certain 
food worldwide. We hypothesized that chronic arsenic 
exposure alters gene expression, potentially by altering 
DNA methylation of genes encoding central components 
of the immune system. We therefore analyzed the transcrip-
tomes (by RNA sequencing) and methylomes (by target-
enrichment next-generation sequencing) of primary CD4-
positive T cells from matched groups of four women each 
in the Argentinean Andes, with fivefold differences in uri-
nary arsenic concentrations (median concentrations of uri-
nary arsenic in the lower- and high-arsenic groups: 65 and 
276 μg/l, respectively). Arsenic exposure was associated 
with genome-wide alterations of gene expression; principal 
component analysis indicated that the exposure explained 
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Introduction
Inorganic arsenic occurs in drinking water worldwide and 
in certain foods, mainly rice-based products. Long-term 
exposure to inorganic arsenic is a strong risk factor for 
different types of cancers as well as numerous non-cancer 
conditions, such as cardiovascular and lung diseases (IARC 
2012). More recently, studies have identified immunotoxic 
effects of arsenic. For example, studies on newborns and 
children found that exposure to arsenic during pregnancy 
was associated with immunosuppressive effects, such 
as decreased thymus size and impaired thymic function, 
altered cytokine expression, and increased susceptibility 
to infections (Moore et al. 2009; Raqib et al. 2009; Ahmed 
et al. 2011,  2012, 2014; Rahman et al. 2011; Farzan et al. 
2016). Arsenic-exposed adults and children had reduced 
proliferation of lymphocytes, fewer CD4-positive T cells, 
altered CD4 + :CD8 + T cell ratio, and fewer T-regulatory 
cells (Biswas et al. 2008; Hernandez-Castro et al. 2009; 
Kile et al. 2014; Nadeau et al. 2014). A few studies have 
reported that arsenic exposure may also increase the risk 
of allergies and autoimmune diseases (Tseng 2004; Soto-
Pena et al. 2006). These findings suggest that arsenic expo-
sure could result in both immune suppression and immune 
stimulation.
The mechanisms behind the immunotoxic effects of 
arsenic remain unclear (Ahmed et al. 2014; Ferrario et al. 
2016). One potential mechanism is that arsenic could 
interfere with the expression of immune-related genes. 
This could result in failure to maintain homeostasis in the 
immune response to foreign antigens, potentially leading to 
immune dysfunction and immune-related diseases. In sup-
port of such a mechanism, microarray-based epidemiologi-
cal studies have shown that arsenic exposure is associated 
with altered expression of immune-related genes in whole 
blood (Argos et al. 2006; Andrew et al. 2008; Salgado-Bus-
tamante et al. 2010). The mode of action by which arse-
nic changes gene expression could, as recently indicated, 
occur by disturbing epigenetic processes that regulate gene 
expression, such as DNA methylation (Pilsner et al. 2012; 
Koestler et al. 2013; Broberg et al. 2014; Kile et al. 2014; 
Cardenas et al. 2015; Rojas et al. 2015).
We hypothesized that chronic arsenic exposure affects 
gene expression via alteration of DNA methylation of cen-
tral components of the immune system. To evaluate this, 
we performed next-generation sequencing (NGS) of the 
transcriptome (by RNA sequencing) and the methylome 
(by target-enrichment NGS) of primary CD4-positive T 
cells, key immune cells in the defense against infections, 
in individuals chronically exposed to inorganic arsenic via 
drinking water.
Methods
Study participants, CD4‑positive cell enrichment, 
and measurement of arsenic
This study involved women living in San Antonio de los 
Cobres and surrounding villages at around 4000 m above 
sea level in the Andes Mountains, Salta Province, Argen-
tina. This area has varying concentrations of arsenic in the 
drinking water, but little industrial or traffic pollution (Con-
cha et al. 2010). This population has been found to have an 
efficient metabolism of arsenic, i.e., they efficiently meth-
ylate inorganic arsenic to dimethylarsinic acid (DMA) with 
little excretion of the monomethylated metabolite, MMA, 
in urine (Vahter et al. 1995).
The study had 34 women enrolled in 2011. A detailed 
description of the study group has been published previ-
ously (Harari et al. 2013). Blood samples from the first 
20 women recruited were sorted for CD4-positive T cells 
immediately after blood collection (K2EDTA tubes (Vacu-
ette, Greiner Bio-One GmbH, Greiner, Germany), using 
the Dynabeads CD4 kit (Life Technologies, USA) and fol-
lowing the manufacturer’s protocol. Subsequently, RNA 
and DNA were extracted with the AllPrep DNA/RNA/
Protein Mini kit (Qiagen, Hilden, Germany). Exposure to 
arsenic was assessed based on the sum concentration of 
metabolites of inorganic arsenic in urine (inorganic arsenic, 
MMA, and DMA), as measured by high-performance liq-
uid chromatography (Agilent 1100 Series System, Agilent 
Technologies, Waldbronn, Germany) coupled with hydride 
generation and inductively coupled plasma mass spectrom-
etry (Agilent 7500ce; Agilent Technologies, Tokyo, Japan) 
(HPLC-HG-ICPMS), as described previously (Concha 
et al. 2010). To correct for variation in urine dilution, we 
adjusted the obtained concentrations for the average spe-
cific gravity mean specific gravity of urine (1.020 g/mL), 
determined by a digital refractometer (EUROMEX RD 712 
clinical refractometer; EUROMEX, Arnhem, the Nether-
lands). To obtain a large contrast in exposure, we selected 
samples from the eight women who showed the great-
est differences in arsenic exposure (four with high expo-
sure and four with lower exposure) and that had similar 
age and BMI. However, there was an overlap between the 
samples used for DNA and RNA analyses for only three of 
the women, due to limitations in sample amount. For the 
transcriptome analysis all samples were analyzed individu-
ally, and for the methylome analysis the samples in each 
exposure group were pooled. None of the women reported 
any disease or other health problems, and none reported 
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drinking alcohol or smoking. The high- and low-exposure 
groups showed a fourfold to fivefold difference in urinary 
arsenic concentrations (Table S1).
Transcriptome characterization: RNA sequencing 
(RNA‑seq)
RNA concentration and purity were evaluated on a NanoDrop 
spectrophotometer, and RNA integrity (RIN) was evaluated 
on a Bioanalyzer 2100; the results showed good RNA quality 
(RIN > 7.5). Total RNA was used to prepare libraries, which 
were sequenced as paired-end, 100-bp reads on an Illumina 
HIseq 2500 (HiSeq Control Software 2.2.38/RTA 1.18.61). 
Library construction and sequencing were performed accord-
ing to the manufacturer’s protocols by researchers at The 
Swedish National Center for Molecular Biosciences, Science 
for Life Laboratory (SciLifeLab), Stockholm, Sweden.
Methylome characterization: target‑enrichment NGS
Equal quantities of DNA from all four women (250 ng) 
for each exposure group were pooled and sequenced in 
two technical replicates. Sample processing included DNA 
quality control (using Qubit assays, from Life Technolo-
gies, USA, and Bioanalyzer, from Agilent, USA), target 
enrichment, bisulfite modification, library preparation, and 
sequencing. Target enrichment was performed with Sure-
SelectXT Human Methyl-Seq kit (Agilent, USA), includ-
ing the following genomic sequences likely to undergo 
changes in methylation: CpG islands, shores, and shelves, 
DNase I hypersensitive sites, Refseq genes, and Ensembl 
regulatory features. The enriched products were bisulfite 
treated with the Zymo EZ DNA Methylation Lightning kit 
(Zymo Research, USA) and sequenced by HiSeq 2500, in 
High Output mode 2 × 100 bp with the TruSeq SBS and 
the TruSeq PE Cluster kits, both v3 (Illumina, USA). The 
sample preparation was performed according to the manu-
facturers’ protocols by SciLifeLab.
MS‑HRM analysis
Methylation-sensitive high-resolution melting (MS-HRM) 
assays were designed and optimized as described previ-
ously (Wojdacz and Dobrovic 2007). LightCycler 480 
(Roche, Germany) and LightCycler 480 High Resolution 
Melting Master (Roche) PCR chemistry were used.
RNA‑seq data analysis
RNA-seq reads were processed with TrimGalore (v0.3.7) for 
adapter removal and adaptive trimming. Alignment was per-
formed with TopHat (v2.0.12), and reads were counted with 
HT-seq (v0.6.1) with GENCODE V19 GTF annotation. The 
features with zero counts were removed, and the size fac-
tor was estimated to normalize the libraries. The cumulative 
distribution of the counts before and after normalization was 
examined to check for proper normalization. Regularized log2 
transformation (due to skewed data) was applied for further 
visualization and data exploration. Pairwise correlation and 
distance between samples were calculated and visualized, and 
principal component analysis (PCA) was used to explore sam-
ple clustering. The variability of gene expression was meas-
ured by coefficient of variation (standard deviation divided by 
the mean), and the variance explained was calculated on the 
top 20% variable genes ranked using the coefficient of vari-
ation. Differential expression analysis was performed using 
DESeq 2, contrasting high- vs. low-arsenic exposure groups. 
Differentially expressed genes (DEGs) were defined as hav-
ing a log-twofold change in expression (log2FC) between 
arsenic exposure groups and with a false discovery rate (FDR) 
adjusted p value (q) <0.05. DEGs with a positive log-two-
fold change in the group with higher exposure, compared to 
the group with lower exposure, were defined as upregulated, 
while DEGs with a negative log-twofold change in the group 
with higher exposure compared to the group with lower expo-
sure were defined as downregulated. Independent filtering was 
employed to calculate cutoff (<2.7) for the number of genes 
with low expression. There were 28,351 input genes, of which 
11,326 (40%) showed low expression (<2.7) and 69 were 
defined as outliers (genes whose observed counts might not fit 
to a negative binominal distribution). Heatmaps were obtained 
for the DEGs. Enrichment for gene ontology was analyzed 
using TopGo with a Fisher test and the algorithm weight01, to 
take into account the structure of the gene ontology tree and to 
eliminate redundancy.
Target‑enrichment NGS data analysis
Adapter removal, adaptive trimming (quality score <28), and 
5′ clipping (4 nucleotides) were performed using Trim Galore 
(v0.3.3). Trimmed sequences were mapped to the human 
genome (build hg19), de-duplication was performed, and 
methylation calls were extracted using Bismark (v0.10.0, with 
Bowtie2 v2.0.6) (Krueger and Andrews 2011). Downstream 
analysis was performed using bsseq (Hansen et al. 2012). 
CpGs with ≥10 × coverage in all samples were retained, 
and 2,705,455 CpGs were included in subsequent analysis. 
Genomic clusters of CpGs were identified: Regions covered 
by the capture probes were extended 100 bp on either side, and 
regions separated by <300 bp were merged into single clus-
ters. To identify differentially methylated regions (DMRs), we 
first calculated a difference in methylation (∆Meth) for each 
CpG position between high- and low-exposure groups. The 
function “regionFinder” was used in the bumphunter package 
version 1.2.0 [modified from a previously published method 
(Jaffe et al. 2012)], providing the locations of the clusters and 
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using a cutoff of ∆Meth = 10%. The DMRs were then filtered 
for those with at least four CpGs. DMRs with higher meth-
ylation in the high-exposure group compared to the lower-
exposure group were defined as hypermethylated; DMRs with 
lower methylation in the high-exposure group compared to the 
lower-exposure group were defined as hypomethylated. For 
evaluation of technical reproducibility, SeqMonk (Zhao et al. 
2014) was used to generate cumulative distribution plots that 
describe the methylation level at each CpG site versus a num-
ber of CpG sites with a given methylation level. The GREAT 
platform was used for analysis of gene ontology (McLean 
et al. 2010).
Alignment RNA‑seq and target‑enrichment NGS
Gene overlap for DMRs and DEGs that were both statisti-
cally significantly associated with arsenic exposure group 
was further evaluated. DMRs included in these analy-
ses were restricted to those in promoter regions, defined 
as within 500-base-pair downstream and 1500-base-pair 
upstream of the transcription start site.
Results
Descriptive data
We compared the transcriptomes and methylomes of 
CD4-positive T cells from four women with high-arsenic 
exposure (~300 µg/L in urine) to those from four women 
with lower-arsenic exposure (~60 µg/L; Table S1). The two 
exposure groups and the women evaluated for transcrip-
tomes and methylomes showed no statistically significant 
differences in age, body mass index (BMI), or coca chew-
ing (Table S1).
Transcriptomics of CD4‑positive T cells
We did not observe any bias in the distribution of number 
of transcripts, i.e., count data, with respect to exposure 
group, or any sample outliers when performing pairwise 
scatterplots of the samples (data not shown).
We performed PCA to evaluate the genome-wide effects 
of arsenic on gene expression in CD4-positive T cells. 
The first principal component clearly separated samples 
based on their exposure group and explained 53% of the 
variance in gene expression among the top 20% variable 
genes (based on coefficient of variation) (Fig. 1, left panel). 
We identified multiple DEGs between arsenic exposure 
groups (Fig. 1, right panel): out of 28,351 input genes, the 
total fraction of DEGs, up- (9.7%, 2744 genes) or down-
regulated (9%, 2553 genes) in the high-arsenic group was 
18.7%. We found the largest log2FC for downregulated 
genes: 79 genes showed a log2FC below −3, with a maxi-
mum of −4.7. For upregulated DEGs, 20 genes showed a 
log2FC above 3 with a maximum of 4.0.
Among the top 10 DEGs (based on p value), four have 
been linked to immune system function, and all were 
Fig. 1  Principal components analysis (left panel) and heatmap (right 
panel) for differently expressed genes between high- and lower-
arsenic exposure groups. In the principal components analysis, the 
first component separates samples based on their exposure group and 
explains 53% of the variance in gene expression for the top 20% vari-
able genes. In the heatmap, the row Z-score of differentially expressed 
genes is plotted, which shows the relative change for each row (gene). 
Samples are correctly clustered according to the exposure group
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downregulated in the high-arsenic exposure group (Table 
S2): these genes encode tumor necrosis factor, alpha-
induced protein 3 (TNFAIP3), CD69 molecule (CD69), 
SBDS ribosome assembly guanine nucleotide exchange 
factor (SBDS), and DNA-damage-inducible transcript 3 
(DDIT3). Other significantly downregulated immune-
related DEGs included TNIP1, TNIP2, TNF, IFNG, IL10, 
IL12A, as well as several genes related to MHC class 2 
(HLA-DRA, HLA-DQA2, HLA-DPB1, HLA-DMA), and 
the nuclear factor kappa-light-chain-enhancer of activated 
B cells (NF-kappa-beta complex: REL, RELA, and RELB) 
(Table 1). Upregulated immune-related genes included IL16 
and IL24 (encoding cytokines), TLR1, TLR4, TLR5, TLR6, 
TLR7, TLR8, and TLR10 (encoding Toll-like receptors), and 
genes coding signal transducer and activator of transcription 
(STAT) proteins (Table 1). Also, some important apoptosis-
related genes were upregulated, such as BCL2, FASLG, 
MAF, and CASP2 as well as CASP3, CASP6, CASP8, and 
CASP10. We note that DNA (cytosine-5-)-methyltransferase 
1 (DNMT1) was upregulated (log2FC = 0.59, q = 0.043), 
but none of the de novo DNA methyltransferases (DNMT3A, 
DNMT3B, and DNMT3L) was differently expressed.
Table 1  Selection of immune-
related differentially expressed 
genes (DEGs) between high-
arsenic (n = 4) and lower-
arsenic (n = 4) exposure groups
The DEGs are sorted based on p value (immune genes presented in Table S2 are not included)
a  Log2FC = log-twofold change, q = FDR-adjusted p value
Gene name Gene description Log2FC
a Qa
RELB v-rel avian reticuloendotheliosis viral oncogene homolog B −1.83 4.1 × 10−19
TNF Tumor necrosis factor −2.70 5.2 × 10−16
CASP3 Caspase 3, apoptosis-related cysteine peptidase 1.70 2.8 × 10−12
IFNG Interferon, gamma −2.45 5.8 × 10−10
TLR8 Toll-like receptor 8 −2.65 1.0 × 10−08
CASP10 Caspase 10, apoptosis-related cysteine peptidase 0.98 2.6 × 10−08
HLA-DQA2 Major histocompatibility complex, class II, DQ alpha 2 −1.56 8.4 × 10−08
TLR4 Toll-like receptor 4 2.35 1.8 × 10−06
TLR10 Toll-like receptor 10 2.14 5.3 × 10−06
BCL2 B cell CLL/lymphoma 2 1.20 7.6 × 10−06
CASP6 Caspase 6, apoptosis-related cysteine peptidase 1.15 1.2 × 10−05
TLR7 Toll-like receptor 7 1.96 1.4 × 10−05
MAF v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog 1.16 4.4 × 10−05
RELA v-rel avian reticuloendotheliosis viral oncogene homolog A −0.98 0.0001
IL12A Interleukin 12A −2.04 0.0001
STAT2 Signal transducer and activator of transcription 2 0.98 0.001
TLR5 Toll-like receptor 5 1.63 0.002
STAT5A Signal transducer and activator of transcription 5A 0.61 0.002
REL v-rel avian reticuloendotheliosis viral oncogene homolog −0.96 0.002
IL24 Interleukin 24 1.20 0.002
IL16 Interleukin 16 0.94 0.002
TNIP1 TNFAIP3 interacting protein 1 −0.59 0.003
CASP8 Caspase 8, apoptosis-related cysteine peptidase 1.00 0.003
IL10 Interleukin 10 −2.10 0.003
STAT1 Signal transducer and activator of transcription 1 1.15 0.003
STAT3 Signal transducer and activator of transcription 33response factor) 0.52 0.004
TLR1 Toll-like receptor 1 1.09 0.008
FASLG Fas ligand (TNF superfamily, member 6) 1.83 0.008
TNIP2 TNFAIP3 interacting protein 2 −0.81 0.008
HLA-DMA Major histocompatibility complex, class II, DM alpha −0.83 0.015
HLA-DPB1 Major histocompatibility complex, class II, DP beta 1 −0.84 0.016
TLR6 Toll-like receptor 6 1.19 0.017
CASP2 Caspase 2, apoptosis-related cysteine peptidase 0.57 0.017
HLA-DRA Major histocompatibility complex, class II, DR alpha −0.85 0.029
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We then performed a gene ontology analysis with the 
topGO algorithm, considering the upregulated and down-
regulated DEGs separately and together. The top gene 
ontologies for the downregulated DEGs were related to 
RNA metabolism, including one category for viral tran-
scription. The top gene ontology category for upregulated 
DEGs was regulation of transcription, DNA-templated. In 
general, categories related to RNA metabolism were sig-
nificantly enriched among both the up- and downregulated 
DEGs, including general transcriptional and translational 
processes (Table S3).
Methylomics of CD4‑positive cells
For each exposure group, we used bisulfite sequencing to 
examine two technical replicates of pooled DNA from all 
individuals in each exposure group and evaluated the tech-
nical variability of the data by plotting the cumulative dis-
tribution of methylation (Figure S1). The two replicates 
were almost identical, indicating very little technical vari-
ability in the data. A clear shift between the plots of the 
high- and low-exposure groups suggested that a large num-
ber of CpG sites were differentially methylated between the 
exposure groups. To evaluate the epigenome-wide effect 
of arsenic exposure, we computed methylation levels for 
each site and compared the number of CpGs showing full 
methylation (defined as >80% methylation) between expo-
sure groups. We found that in the two technical replicates 
of the lower-exposure group, 41.3 and 41.2% of the CpG 
sites showed full methylation, compared with 44.2% in 
both technical replicates of the high-exposure group, i.e., 
3 percentage points higher full methylation, genome wide. 
DNA methylation increased for the high-exposure group at 
certain functional elements, particularly in CpG shelves, 
gene bodies, CpG shores, and gene promoters (Figure S2), 
but not in CpG islands.
We identified 1168 differentially methylated regions 
(DMRs) of which 391 (33.5%) showed hypermethylation 
and 777 (66.5%) hypomethylation in the high-exposure 
group. The top 10 DMRs are presented in Table S4, and 
examples of statistically significant methylation changes 
at a single-base resolution are shown in Fig. 2.Among the 
top 50 DMRs, two immune-related genes have previously 
been associated with arsenic exposure (Ramsey et al. 2013; 
Ding et al. 2016), encoding secretoglobin family 3A mem-
ber 1 (SCGB3A1) and nuclear factor of activated T cells 1 
(NFATC1). Both genes were hypomethylated in the high-
arsenic group. The 1168 DMRs included several immune-
related genes, such as interleukins IL9, IL10, IL13, IL32 
(hypermethylated), IL36A (hypomethylated), members of 
the interferon regulatory factor (IRF) family; IRF1, IRF4, 
IRF7, and IRF8 (all hypermethylated), members of the 
cluster of differentiation (CD) family CD2, CD58 (hyper-
methylated), CD6, CD27, CD40 (hypomethylated), two 
genes related to MHC class (HLA-DQAI, which was hyper-
methylated, and HLA-DRB5, for which one DMR was 
hypermethylated and one DMR hypomethylated), as well 
as IFNG and TLR10.
The gene ontology analyses of hypermethylated DMRs 
(performed by the GREAT platform) showed an enrich-
ment of cellular processes that relate to immune function 
of CD4-positive T cells, such as processes related to immu-
noglobulins and isotype switching (positive regulation of 
isotype switching, positive regulation of isotype switching 
to IgE isotypes, positive regulation of isotype switching to 
IgG isotypes, regulation of immunoglobulin production) 
and lymphocyte activation and differentiation (Table 2). By 
contrast, hypomethylated DMRs showed an enrichment of 
developmental processes, such as embryonic organ mor-
phogenesis (Table 2). Hypermethylated DMRs also showed 
enrichment of genes related to V(D)J recombination.
To validate the accuracy of the methylome analysis, we 
analyzed four statistically significant DMRs using MS-
HRM assays, and all confirmed a methylation difference 
between samples from high- and lower-exposure groups 
(data not shown).
Alignment of DEGs and promoter DMRs associated 
with arsenic exposure group
In total, 32 genes had DMRs and DEGs that both sta-
tistically significantly associated with arsenic exposure 
group (top 10 genes in Table S5). Two of the 32 genes are 
involved in immune responses (Miyamoto et al. 1988; Dorn 
et al. 2007) (Figure S3): (1) interferon regulatory factor 1 
(IRF1), for which the gene expression was downregulated 
and the DMR hypermethylated, and (2) ras homolog fam-
ily member H (RHOH) for which the gene expression was 
downregulated and the DMR hypomethylated.
Discussion
Our study suggests that chronic arsenic exposure through 
drinking water is related to changes in the transcriptome 
and methylome, both genome wide and for specific genes, 
of CD4-positive T cells in Andean women. Several key 
genes in the immune system were differently expressed at 
higher-arsenic exposure, and DMRs that were hypermeth-
ylated in the high-arsenic exposure group showed enrich-
ment of immune-related processes that constitute the basic 
functions of CD4-positive T cells. These findings support 
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the hypothesis that elevated arsenic exposure may cause 
immunotoxicity by interfering with gene expression and 
gene regulation. Still, we could not link many DMRs in 
promoter regions to changes in gene expression, which 
may be due to limited sequencing coverage, few samples 
analyzed and only partial overlap, or the arsenic-related 
changes in gene expression may be partly mediated by 
mechanisms other than DNA methylation.
Fig. 2  Single CpG resolution of differences in DNA methylation 
between arsenic exposure groups. a−c Differentially methylated 
regions (DMRs) hypermethylated in the high-arsenic exposure group; 
e−g DMRs hypomethylated in the high-arsenic exposure group. The 
chromosome number and genomic position are shown above the fig-
ure. Exposure groups are shown in blue (lower-arsenic exposure) and 
red (high exposure); vertical bars represent CpGs covered by tar-
geted sequencing in specific regions. The methylation on the y-axis is 
shown as beta values. Green boxes are regions of the genome where 
DMRs (defined here as four consecutive CpG sites with a difference 
in methylation above 10% between high- and low-arsenic groups) 
were identified. Bottom bars indicate distances of the DMR to the 
closest gene (G) and CpG island (CGI)
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Arsenic exposure was associated with changes 
in genome‑wide gene expression and expression 
of specific immune‑related genes
Arsenic exposure was associated with genome-wide gene 
expression. In spite of the few samples analyzed, the first 
principal component, which separated samples based 
on their exposure group, explained more than half of the 
observed variance in gene expression for the top 20% 
variable genes and more than 5000 genes were differently 
expressed between the arsenic exposure groups. Among 
the top ten DEGs, four (all downregulated) have been 
linked to immune system function, and for three of these 
(TNFAIP3, CD69, and DDIT3), changes in expression have 
previously been associated with different types of arsenic 
exposure (Wang et al. 2006; Andrew et al. 2008; Li et al. 
2013; Nadeau et al. 2014). The deubiquitinating enzyme 
TNFAIP3 (also called A20) is an important negative 
regulator of innate and adaptive immunity. TNFAIP3 
participates in immune and inflammatory responses sig-
naled by cytokines, such as TNF, and TNFAIP3 is rapidly 
induced by TNF (Dixit et al. 1990). TNFAIP3 also responds 
to signaling by Toll-like receptors (Boone et al. 2004) and 
affects immune responses by strongly inhibiting NF-kappa-
B activity (Heyninck and Beyaert 2005). TNFAIP3 is most 
highly expressed in T cells and, in particular, in CD4 posi-
tive T cells (http://genevisible.com/tissues/HS/UniProt/
P21580). The downregulation of TNFAIP3 is consistent 
with the downregulation of TNF with increasing arsenic 
exposure identified in this study, as well as with the down-
regulation of TNFAIP3-interacting proteins 1 and 2 (TNIP1 
and TNIP2). Also, TNFAIP3 was upregulated in a multiple 
myeloma cell line after treatment with realgar, an arsenic 
sulfide mineral (Wang et al. 2006).
CD69 codes for a surface marker expressed on CD4 
positive T cells. The activation of T lymphocytes induces 
Table 2  Top gene ontologies (GOs) related to differently methylated regions between high-arsenic (n = 4) and lower-arsenic (n = 4) exposure 
groups
GO ID Term P value
DMRs hypermethylated in high‑arsenic 
exposure group
 GO:0045830 Positive regulation of isotype switching 5.25 × 10−6
 GO:0045911 Positive regulation of DNA recombination 8.91 × 10−6
 GO:0046649 Lymphocyte activation 1.45 × 10−5
 GO:0048295 Positive regulation of isotype switching to IgE isotypes 2.95 × 10−5
 GO:0002637 Regulation of immunoglobulin production 3.09 × 10−5
 GO:0030098 Lymphocyte differentiation 3.89 × 10−5
 GO:0006414 Translational elongation 4.07 × 10−5
 GO:0002703 Regulation of leukocyte-mediated immunity 5.5 × 10−5
 GO:0045087 Innate immune response 6.17 × 10−5
 GO:0045191 Regulation of isotype switching 6.31 × 10−5
 GO:0048304 Positive regulation of isotype switching to IgG isotypes 7.24 × 10−5
DMRs hypomethylated in high‑arsenic 
exposure group
 GO:0048562 Embryonic organ morphogenesis 1.26 × 10−9
 GO:0060741 Prostate gland stromal morphogenesis 1.78 × 10−6
 GO:0035518 Histone H2A monoubiquitination 3.31 × 10−6
 GO:0045668 Negative regulation of osteoblast differentiation 8.13 × 10−6
 GO:0060684 Epithelial–mesenchymal cell signaling 9.55 × 10−6
 GO:0033522 Histone H2A ubiquitination 1.29 × 10−5
 GO:0070372 Regulation of ERK1 and ERK2 cascade 1.48 × 10−5
 GO:0033151 V(D)J recombination 1.58 × 10−5
 GO:0048701 Embryonic cranial skeleton morphogenesis 2.19 × 10−5
 GO:0043433 Negative regulation of sequence-specific DNA binding transcription factor activity 2.19 × 10−5
 GO:0010464 Regulation of mesenchymal cell proliferation 2.29 × 10−5
 GO:0070374 Positive regulation of ERK1 and ERK2 cascade 2.82 × 10−5
 GO:0010830 Regulation of myotube differentiation 3.16 × 10−5
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expression of CD69. CD69 appears to be the earliest induc-
ible cell surface glycoprotein acquired during lymphoid 
activation and is involved in lymphocyte proliferation. 
CD69 functions as a signal-transmitting receptor in lym-
phocytes, including NK cells, and platelets (Cambiaggi 
et al. 1992). Downregulation of CD69, as observed here, 
could thus be linked to decreased activation of T lym-
phocytes. The downregulation of CD69 is in line with the 
results from a population exposed to low levels of arsenic in 
New Hampshire (N = 21), where increasing arsenic expo-
sure from drinking water was associated with decreased 
CD69 expression in peripheral blood lymphocytes (Andrew 
et al. 2008). Another study in New Hampshire showed 
that in utero environmental arsenic exposure was inversely 
related to absolute total cord blood CD69 + T cell counts 
(Nadeau et al. 2014).
DNA-damage-inducible transcript 3 (DDIT3), also 
known as C/EBP-homologous protein (CHOP), encodes a 
transcription factor. DDIT3 has previously been shown to 
be upregulated in CD4-positive T cells in mice in response 
to arsenic trioxide treatment (Li et al. 2013). The upregula-
tion of TNFAIP3 and DDIT3 found in previous studies is in 
contrast to the downregulation of these genes observed in 
our study. However, the expression of these genes could be 
dose dependent, since the doses of arsenic trioxide or real-
gar were much higher than the doses from drinking water 
in the current study.
Furthermore, we found that several key players in the 
immune system were downregulated, such as TNF, IFNG, 
and IL10, as well as several genes related to MHC class 
2 and the NF-kappa-B complex, while several key genes 
related to apoptosis were upregulated. Most of these find-
ings are in accordance with previous studies investigat-
ing the association between gene expression (measured 
by microarray) and arsenic exposure in peripheral blood 
(Dangleben et al. 2013). Apoptosis is important for the 
homeostasis of the immune system, and abnormal immune 
cell apoptosis can contribute to dysregulation of immune 
function (Boise et al. 1995). The decrease in T cells with 
increasing arsenic exposure could be mediated by the 
upregulation of apoptotic genes. The regulation of mRNA 
levels of these genes may hypothetically be due to an effect 
of arsenic exposure on RNA metabolism, since several 
gene ontologies related to RNA metabolism were strongly 
enriched in the high-arsenic group.
Exposure to arsenic influenced genome‑wide 
and gene‑specific 5‑methylcytosine methylation
Our analysis of the methylome indicated that 3% of the 
genome-wide CpGs gained full methylation in the high-
arsenic samples. By contrast, earlier in vitro and in vivo 
experiments associated arsenic exposure with global 
hypomethylation, measured as methylation of repetitive 
elements (Intarasunanont et al. 2012; Bailey and Fry 2014; 
Kile et al. 2014). Here, we measured methylation at CpG 
sites in regulatory sequences, which showed that these 
regions were hypermethylated in women in the high-arse-
nic exposure group. This suggests that in response to arse-
nic exposure, transcriptionally active parts of the genome 
gain methylation while repetitive elements lose methyla-
tion. Arsenic exposure did not appear to affect the methyla-
tion of CpG islands, but previous work showed that those 
elements are generally protected from changes in methyla-
tion (Deaton and Bird 2011). The increase in genome-wide 
DNA methylation may partly be explained by the upregu-
lation of DNMT1 expression in the high-arsenic exposure 
group, as DNMT1 is the major enzyme responsible for 
maintaining methylation patterns following DNA replica-
tion in somatic cells.
In addition, arsenic exposure also seemed to be associ-
ated with locus-specific DNA methylation. Two of the top 
50 DMRs in the arsenic exposure group (both hypometh-
ylated) covered immune-related genes that have previously 
been associated with gene expression in relation to arsenic. 
The secretoglobin gene SCGB3A1 was upregulated in the 
lung in C57BL/6 mice exposed to arsenic in drinking water 
(Ramsey et al. 2013). Secretoglobins have anti-inflam-
matory and immunomodulatory functions (Jackson et al. 
2011). NFATC1 plays a central role in inducible transcrip-
tion of cytokine genes in T cells (Chuvpilo et al. 1999) and 
was downregulated by arsenic in HCT116, a colon cancer 
cell line (Ding et al. 2016).
Gene ontology analysis of the DMRs that were hyper-
methylated in the high-arsenic group showed enrichment 
of immune-related processes that constitute the basic 
functions of CD4-positive T cells, such as isotype switch-
ing, especially the switch to IgE or IgG. Hypomethylated 
DMRs, by contrast, were linked to embryonic organ devel-
opment, in particular. This is of interest, as a previous study 
found genome-wide hypomethylation in blood from new-
borns with elevated prenatal exposure to arsenic (Broberg 
et al. 2014).
Differentially methylated regions in gene promoters 
correlated partly with gene expression
Thirty-two genes were significantly differentially expressed 
in the transcriptome analyses and also harbored a DMR. 
Two of the top genes, IRF1 and RHOH, are involved in 
immune responses, and both were downregulated in the 
high-arsenic group. IRF1 is a member of the interferon 
regulatory transcription factor (IRF) family and activates 
transcription of interferons alpha and beta, as well as of 
genes induced by interferons alpha, beta, and gamma (Miy-
amoto et al. 1988). Thus, the downregulation of IRF1 may 
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be linked to the downregulation of IFNG seen in this study. 
IRF1 plays an important role in Th1 development and 
maturation of T helper cells (Lohoff and Mak 2005) and 
is involved in the suppression of regulatory T cell develop-
ment (Fragale et al. 2008). RHOH is a critical regulator of 
thymocyte development and T cell antigen receptor signal-
ing (Dorn et al. 2007).
Strengths and limitations of the current study
The main strength of this study was that we used large-
scale NGS on sorted CD4-positive T cells, which allowed 
us to conduct a genome-wide investigation of how this spe-
cific immune cell may respond to arsenic exposure. The 
technical variability in our sequencing data was minor, and 
the contrast in arsenic exposure was large; this enabled us 
to reveal group differences in the methylome and the tran-
scriptome, despite the limited number of samples. How-
ever, further studies are needed for evaluation of causality 
as well as the dose–effect relationships. To note, the group 
with lower exposure was also somewhat exposed to arsenic; 
thus, there is no unexposed group in this study. A limitation 
of the study is the small number of samples and that the 
samples for the two different sequencing analyses were not 
completely overlapping, due to sample limitations. Also, 
only women were included; thus, we do not know whether 
these results also extend to men. Moreover, this is a unique 
population for studies on the effects of arsenic exposure, as 
they have an efficient metabolism of arsenic (Vahter et al. 
1995), known to be related to lower risk of toxicity This 
population has been exposed to arsenic in drinking water 
for thousands of years and likely has adapted to tolerate 
arsenic (Schlebusch et al. 2013, 2015). Thus, the indicated 
changes in gene expression and DNA methylation may not 
necessarily be considered toxic responses, since they may 
occur following an adaptive response, e.g., acquired resist-
ance over time. Thus, the effects in a population without 
this background may differ from the effects found in this 
study. Further and larger studies, in other populations with 
wide ranges in chronic arsenic exposure, and also including 
men, will be needed to validate the results.
Conclusions
We showed that chronic arsenic exposure from drinking 
water is related to changes in the transcriptome and methy-
lome of CD4-positive T cells, both genome wide and for 
specific genes, supporting the hypothesis that arsenic 
causes immunotoxicity by interfering with gene expression 
and gene regulation.
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